Bialy LP - Search Results

1

Mucosal delivery systems of antihypertensive drugs: A practical approach in general practice.

Bialy LP, Wojcik C, Mlynarczuk-Bialy I. Bialy LP, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Jun;162(2):71-78. doi: 10.5507/bp.2018.022. Epub 2018 May 15. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018. PMID: 29765168 Free article. Review.

2

Localization of a proteasomal antigen in human spermatozoa: immunohistochemical electron microscopic study.

Biały LP, Ziemba HT, Marianowski P, Fracki S, Bury M, Wójcik C. Biały LP, et al. Folia Histochem Cytobiol. 2001;39(2):129-30. Folia Histochem Cytobiol. 2001. PMID: 11374790

3

Effects of the combination of a proteasome inhibitor (PSI) and an inhibitor of ubiquitin-ligases (Leu-Ala) on the ultrastructure of human leukemic U937 cells.

Biały LP, Ziemba H, Pleban E, Wójcik C. Biały LP, et al. Folia Histochem Cytobiol. 2002;40(2):135-6. Folia Histochem Cytobiol. 2002. PMID: 12056612

4

Proteasome localization and ultrastructure of spermatozoa from patients with varicocele--immunoelectron microscopic study.

Ziemba H, Biały LP, Fracki S, Bablok L, Wójcik C. Ziemba H, et al. Among authors: bialy lp. Folia Histochem Cytobiol. 2002;40(2):169-70. Folia Histochem Cytobiol. 2002. PMID: 12056629

5

AAF-cmk sensitizes tumor cells to trail-mediated apoptosis.

Młnarczuk I, Mróz P, Hoser G, Nowis D, Biały ŁP, Ziemba H, Grzela T, Feleszko W, Malejczyk J, Wójcik C, Jakóbisiak M, Gołab J. Młnarczuk I, et al. Among authors: bialy lp. Leuk Res. 2004 Jan;28(1):53-61. doi: 10.1016/s0145-2126(03)00122-x. Leuk Res. 2004. PMID: 14630081

6

Pioglitazone, a PPAR-gamma ligand, exerts cytostatic/cytotoxic effects against cancer cells, that do not result from inhibition of proteasome.

Mrówka P, Głodkowska E, Młynarczuk-Biały I, Biały L, Kuckelkorn U, Nowis D, Makowski M, Legat M, Gołab J. Mrówka P, et al. Acta Biochim Pol. 2008;55(1):75-84. Epub 2008 Mar 10. Acta Biochim Pol. 2008. PMID: 18327303 Free article.

7

Synthesis of novel, peptidic kinase inhibitors with cytostatic/cytotoxic activity.

Szymanski W, Zwolinska M, Klossowski S, Młynarczuk-Biały I, Biały L, Issat T, Malejczyk J, Ostaszewski R. Szymanski W, et al. Bioorg Med Chem. 2014 Mar 1;22(5):1773-81. doi: 10.1016/j.bmc.2014.01.005. Epub 2014 Jan 10. Bioorg Med Chem. 2014. PMID: 24507826

8

Biodistribution and Efficacy Studies of the Proteasome Inhibitor BSc2118 in a Mouse Melanoma Model.

Mlynarczuk-Bialy I, Doeppner TR, Golab J, Nowis D, Wilczynski GM, Parobczak K, Wigand ME, Hajdamowicz M, Biały LP, Aniolek O, Henklein P, Bähr M, Schmidt B, Kuckelkorn U, Kloetzel PM. Mlynarczuk-Bialy I, et al. Among authors: bialy lp. Transl Oncol. 2014 Oct 24;7(5):570-9. doi: 10.1016/j.tranon.2014.07.002. eCollection 2014 Oct. Transl Oncol. 2014. PMID: 25389452 Free PMC article.

9

Changes in spatio-temporal localization of tripeptidyl peptidase II (TPPII) in murine colon adenocarcinoma cells during aggresome formation: a microscopy study based on a novel fluorescent proteasome inhibitor.

Bialy LP, Kuckelkorn U, Henklein P, Fayet J, Wilczyński GM, Kamiński A, Mlynarczuk-Bialy I. Bialy LP, et al. Histol Histopathol. 2019 Apr;34(4):359-372. doi: 10.14670/HH-18-042. Epub 2018 Sep 18. Histol Histopathol. 2019. PMID: 30226264

10

Semispecific TPPII inhibitor Ala-Ala-Phe-chloromethylketone (AAF-cmk) displays cytotoxic activity by induction of apoptosis, autophagy and protein aggregation in U937 cells.

Bialy LP, Fayet J, Wilczynski GM, Mlynarczuk-Bialy I. Bialy LP, et al. Folia Histochem Cytobiol. 2018;56(4):185-194. doi: 10.5603/FHC.a2018.0020. Epub 2018 Oct 8. Folia Histochem Cytobiol. 2018. PMID: 30294774 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page